Candida auris Infection in a Meningococcal Septicemia Survivor, Poland

Area of Science:

• Medical Mycology
• Infectious Diseases
• Clinical Microbiology

Background:

• Candida auris is a significant global health concern due to its emergence as a difficult-to-identify pathogen.
• Standard laboratory methods may misidentify C. auris, potentially leading to incorrect patient management.
• Rapid and specific diagnostic approaches are essential for timely intervention.

Observation:

• The first reported isolation of C. auris in Poland occurred in February 2019.
• The isolate was obtained from blood cultures and wound swabs of a young male patient with a history of meningococcal septicemia and recent hospitalization in the UAE.
• Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) enabled rapid identification.

Findings:

• The C. auris isolate was successfully identified using MALDI-TOF MS, allowing prompt clinical notification.
• Antifungal treatment and infection control measures were effective in managing the patient's infection.
• Genetic analysis, including ITS sequencing and whole genome sequencing, revealed the isolate belongs to the South Asian lineage (clade I).

Implications:

• Rapid identification of C. auris is critical for preventing outbreaks in healthcare settings.
• Effective infection control strategies are necessary to limit the spread of this opportunistic pathogen.
• Genomic surveillance aids in understanding the geographic distribution and transmission dynamics of C. auris.